Novartis Pharmaceuticals Corporation v. Sun Pharmaceutical Industries Ltd. et al
| Novartis Pharmaceuticals Corporation |
| Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. and Sun Pharma Global FZE |
| 1:2021cv01656 |
| November 23, 2021 |
| US District Court for the District of Delaware |
| Leonard P Stark |
| Patent - Abbreviated New Drug Application(ANDA) |
| 35 U.S.C. ยง 271 |
| None |
Docket Report
RSS Track this Docket
This docket was last retrieved on January 21, 2022. A more recent docket listing may be available from PACER.
| Document Text |
|---|
| Filing 10 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Sun Pharmaceuticals Industries Ltd. for Sun Pharmaceutical Industries, Inc. filed by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc.. (Myer, R.) |
| Filing 9 ANSWER to #1 Complaint, by Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc..(Myer, R.) |
| Filing 8 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharmaceutical Industries, Inc. waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Filing 7 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharma Global FZE waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Filing 6 WAIVER OF SERVICE returned executed by Novartis Pharmaceuticals Corporation: For Sun Pharmaceutical Industries Ltd. waiver sent on 11/30/2021, answer due 1/31/2022. (Silver, Daniel) |
| Case Assigned to Judge Leonard P. Stark. Please include the initials of the Judge (LPS) after the case number on all documents filed. (rjb) |
| Filing 5 Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Novartis AG for Novartis Pharmaceuticals Corporation filed by Novartis Pharmaceuticals Corporation. (twk) |
| Filing 4 Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 11,058,677; 8,927,574; 9,353,088; 9,890,141; 9,085,553. (twk) |
| Filing 3 Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: September 16, 2020 and October 11, 2021. Date of Expiration of Patent: December 18, 2033 (11,058,677); November 12, 2030 (8,927,574); October 21, 2030 (9,353,088); October 21, 2030 (9,890,141); July 25, 2033 (9,085,553). Thirty Month Stay Deadline: 1/11/2024. (twk) |
| Filing 2 Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (twk) |
| Filing 1 COMPLAINT filed against Sun Pharma Global FZE, Sun Pharmaceutical Industries Ltd., Sun Pharmaceutical Industries, Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3749885.) - filed by Novartis Pharmaceuticals Corporation. (Attachments: #1 Exhibit A-E, #2 Civil Cover Sheet)(twk) |
| No Summons Issued. (twk) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Delaware District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
